Key Points
- Q2 2024 revenue was $86.4 million, a 36.5% decrease from Q2 2023.
- GAAP net income fell to $23.8 million, down from $55.7 million in Q2 2023.
- Management revised full-year revenue guidance downward from $485 million-$495 million to $430 million-$440 million.
InMode Ltd. (INMD -1.62%), a leader in minimally invasive aesthetic medical products, reported its Q2 2024 earnings on August 1. The most significant news in this release was a substantial 36.5% decline in revenue and profit year-over-year, driven by macroeconomic factors. Revenue for Q2 2024 was $86.4 million compared to $136.1 million in Q2 2023. GAAP net income dropped sharply to $23.8 million from $55.7 million. Non-GAAP net income decreased to $29.0 million from $62.2 million, and diluted earnings per share were $0.28 (GAAP) and $0.34 (non-GAAP) compared to $0.65 and $0.72, respectively, in Q2 2023. Overall, it was a challenging quarter for the company.
| Metric | Q2 2024 | Management's Expectations | Q2 2023 | Y/Y % Change |
|---|---|---|---|---|
| Revenue | $86.4 million | $102.6 million (Pro-forma) | $136.1 million | -36.51% |
| GAAP Net Income | $23.8 million | $55.7 million | -57.27% | |
| Non-GAAP Net Income | $29.0 million | $62.2 million | -53.38% | |
| GAAP Gross Margin | 80% | 84% | -4.76% | |
| Non-GAAP Operating Margin | 27% | 47% | -42.55% | |
| Source: Expectations based on management's guidance, as provided in 2024-05-02 earnings report. |
Overview of InMode Ltd.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on proprietary radiofrequency-assisted lipolysis (RFAL) and fractional radiofrequency (RF) technologies. The company's primary revenue comes from selling these platforms for aesthetic and medical procedures. Recent focuses include expanding their product range and geographic reach.
The business has been emphasizing its proprietary technology and diverse product range, which are critical for its competitive edge. Key success factors include maintaining a robust cash position and focusing on innovation.
Quarterly Highlights
InMode's Q2 2024 sales faced significant challenges, with revenue dropping to $86.4 million, a 36.5% decrease from $136.1 million in Q2 2023. The company attributed the decline primarily to macroeconomic factors affecting customer financing decisions and production delays.
Management noted that new platforms, IgniteRF and Optimus Max, faced longer production times, impacting revenue. Despite this, these platforms were highlighted as future growth drivers given their advanced technology and expected market demand.
GAAP gross margin declined to 80% from 84% in Q2 2023, and non-GAAP gross margin also fell from 84% to 81%. Operating margins saw notable reductions, with GAAP operating margin dropping to 21% from 42%, and non-GAAP operating margin to 27% versus 47% in Q2 2023.
International revenue accounted for 35% of total sales, down from higher percentages in past periods.
Another noteworthy point was consumables and services revenue, accounting for $21.0 million, down 3% year-over-year. This segment faces slower demand but still shows underlying interest in InMode's offerings.
The total cash position remains strong at $729.2 million. This robust balance sheet provides financial flexibility to navigate current headwinds and invest in future growth.
Financial Outlook
Looking ahead, management revised full-year 2024 revenue guidance downward from $485 million-$495 million to $430 million-$440 million. Non-GAAP earnings per diluted share guidance adjusted to $1.92-$1.96 from the previous $2.01-$2.05.
The upcoming quarters will be crucial. Investors should watch for the rollout of the IgniteRF and Optimus Max platforms, potential easing of macroeconomic pressures, and operational logistics. Continued innovation and successful international expansion are key factors that could drive future performance improvements.
